Tiziana Life Sciences Ltd
TLSA | NASDAQ
$0.62
-$0.02 (-2.82%)
At close: Nov 5, 2026, 4:00 PM ET
$0.62
$0.00 (+0.53%)
After-hours:
Nov 5, 2026, 4:22 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Mar 31, 2022 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 158K | 146K | 88K | 61K | 126K | 41K | -51.92K | 56.54K | -55.84K | n/a | 77.77K |
Gross Profit | -158K | -146K | -88K | -61K | -126K | -41K | -55K | -56.54K | 55.84K | n/a | -77.77K |
Operating Income | -11.42M | -12.33M | -8.96M | -9.19M | -12.89M | -6.23M | -14.88M | -12.34M | -5.52M | -5.2M | -21.22M |
Interest Income | n/a | 14K | 5K | 702K | 224K | 1.15M | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -12.39M | -12.8M | -5.63M | -8.77M | -15.96M | -8.63M | -10.91M | -13.38M | -5.48M | -4.83M | -17.48M |
Net Income | -12.39M | -12.8M | -5.63M | -7.21M | -9.31M | -9.07M | -10.91M | -13.38M | -5.48M | -3.21M | -17.48M |
Selling & General & Admin | 4.83M | 5.15M | 5.63M | 6.48M | 7.61M | 1.37M | -1.73M | 5.53M | -5.46M | 1.47M | 15.09M |
Research & Development | 6.43M | 7.04M | 3.24M | 2.65M | 5.15M | 4.83M | 4.16M | 6.75M | 9.06M | 3.73M | 6.05M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 12.5M | n/a | 1.98M | -2.95M | n/a |
Operating Expenses | 11.26M | 12.18M | 8.87M | 9.13M | 12.76M | 6.19M | 14.93M | 12.28M | 5.57M | 2.25M | 21.14M |
Interest Expense | n/a | 18K | n/a | 6K | n/a | 5K | 6.33K | 8.6K | n/a | 55.83 | 25K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 11.42M | 12.33M | 8.96M | 9.19M | 12.89M | 6.23M | 14.88M | 12.34M | 5.52M | 2.25M | 21.22M |
Income Tax Expense | n/a | n/a | n/a | -1.56M | -6.65M | 449K | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 63.94M | 59.47M | 58.41M | 54.56M | 51.55M | 51.33M | 50.76M | 50.29M | 50.76M | 110.82M | 75.11M |
Shares Outstanding (Diluted) | 63.94M | 59.47M | 58.41M | 54.56M | 51.55M | 51.33M | 50.76M | 50.29M | 50.76M | 110.82M | 75.11M |
EPS (Basic) | -0.19 | -0.22 | -0.10 | -0.13 | -0.18 | -0.18 | -0.20 | -0.28 | -0.10 | -28.90 | -0.24 |
EPS (Diluted) | -0.19 | -0.22 | -0.10 | -0.13 | -0.18 | -0.18 | -0.20 | -0.28 | -0.10 | -28.90 | -0.24 |
EBITDA | -11.26M | -12.18M | -5.54M | -8.7M | -15.9M | -8.58M | -10.85M | -13.32M | -5.47M | -5.2M | -21.14M |
EBIT | -11.42M | -12.33M | -5.63M | -8.76M | -15.96M | -8.62M | -10.91M | -13.37M | -5.48M | -5.2M | -21.22M |
Depreciation & Amortization | 158K | 146K | 88K | 61K | 63K | 41K | 55K | 46K | 5K | 2.5K | 77.77K |
Add to Watchlist
Select watchlists to add or remove TLSA